|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. informed consent and, 94 liability and compensation issues, 193 National Committee for Quality Assurance (NCQA), 171, 172-173, 175, 176, 231, 232 non-biomedical research, 245-246 Research Ethics Review Boards (Research ERBs), 104-105, 107 ACHRE, see Advisory Committee on Human Radiation Experiments Adverse event reporting, 15, 16, 37, 47, 59, 68, 103, 148, 149-150, 153, 154, 157-158, 161, 165, 170, 192, 254, 261 Advisory Committee on Human Radiation Experiments (ACHRE), 4(n.8), 119, 213-214 AIDS, see HIV American Association of University Professors, 43 American Medical Association, 118, 206-207 American Society of Gene Therapy (ASGT), 183 Animal studies, 37, 144, 147, 157, 200, 213, 274, 275 Anthrax, 212 Applied Research Ethics National Association (ARENA), 62, 64, 234 Association for the Accreditation of Human Research Protection Programs (AAHRPP), 4(n.4), 171, 173-175, 176, 232, 245-246 Association of American Medical Colleges (AAMC), 4(n.3), 62, 118, 183 Association of American Universities (AAU), 183 Association of Clinical Research Professionals, 183 Association of the British Pharmaceutical Industry, 194 Assurance of Compliance documents, 140 Attitudes and beliefs see also Psychological effects; Public opinion dignity of research participants, 29, 31, 46, 165, 193-194, 238 informed consent, 125-126, 130-131, 132 participants in research, 125-126, 129-133 religious, 97 committee recommendations, 16, 73, 78, 148-149 defined, 139 Food and Drug Administration (FDA), 69, 73 Research Ethics Review Boards (Research ERBs), 138 Award for Excellence in Human Research Protection, 142 B Bayh-Dole Act, 185 Beaumont, William, 33 Behavioral and social research, see Non-biomedical research Belmont Report, 70, 74-75, 92, 119, 181, 238 Best practices, 61, 106, 107, 163-164, 166, 171, 198 see also Good Clinical Practice (GCP) Biologic license applications, 139 Biomedical Research Alliance of New York (BRANY), 84, 104 Bioterrorism, see Terrorism Britain, see United Kingdom C Center for Drug Evaluation and Research (CDER), 146 Centers for Disease Control and Prevention, 212 Centers for Strategic International Studies, 215 Chief Executive Officers (CEOs), 54, 55, 62, 78, 87, 146, 253 Children, 43 Citizen Advocacy Center, 101, 133, 232 Classified reserach, 213-215 Committee on Human Research Participant Protections (proposed), 199 Common Rule (Federal Policy for the Protection of Human Subjects), 5, 47(n.2), 91, 120, 138, 139, 149, 178, 179, 198, 208, 210, 214, 237, 241-242 see also Institutional Review Boards (IRBs) Compensation for injury, see Liability and compensation Computer applications see also Databases; Internet
|
|
|||||||||||||||
